In 2013, The Cancer Genome Atlas (TCGA) Research Network provided the medical community with a new prognostic classification of endometrial cancer based on the tumor’s molecular biology [73] in four categories: POLE ultra-mutated, microsatellite instability hypermutated, low-copy-number tumor, and high-copy-number tumor. This evidence concerns the gene POLE and endometrial cancer.